Ackman Gets More Involved at Valeant After $764 Million Loss – Bloomberg Business

Billionaire investor Bill Ackman’s Pershing Square Capital Management LP said it will take a much larger role at Valeant Pharmaceuticals International Inc., after in a single day losing about $764 million on the common shares it owns, following the drugmaker’s as much as 51 percent stock drop Tuesday.